Heidenhain variant in two patients with inherited V210I Creutzfeldt-Jakob disease.

Paola Imbriani, Girolama Alessandra Marfia, Maria Grazia Marciani, Anna Poleggi, Maurizio Pocchiari, Gianfranco Puoti, Carlo Caltagirone, Antonio Pisani

Journal: The International journal of neuroscience 2017;126(4):381-3

PMID: 26268049

Abstract

OBJECTIVE

To report two members of the same family carrying the valine to isoleucine point mutation of the prion protein gene (PRNP) and presenting with visual symptoms as initial manifestation as in the "Heidenhain variant" of sporadic Creutzfeldt-Jakob disease (CJD).

METHODS

Patients underwent neurological examination, electroencephalogram (EEG), brain magnetic resonance images (MRI) and cerebrospinal fluid (CSF) analysis including the Real Time Quaking Induced Conversion (RT-QuIC) test. Disease-specific mutations and polymorphism at codon 129 of the PRNP gene were also studied.

RESULTS

Isolated visual symptoms characterized disease onset of both patients followed by progressive neurological signs, dementia and death in 3 (proband) and 9 (his aunt) months. RT-QuIC analysis of CSF samples of both patients revealed the presence of the pathological prion protein and DNA analysis the V210I point mutation of the PRNP and methionine homozygosity at the polymorphic codon 129.

CONCLUSIONS

This report suggests to consider the diagnosis of V210I genetic CJD in patients presenting with the Heidenhain form of CJD and highlights the importance of genetic testing in all patients with isolated visual manifestations at onset followed by progressive neurological signs and dementia.

Address: a Department of Systems Medicine , University of Rome "Tor Vergata" , Rome , Italy.; b Department of Cell Biology and Neurosciences , Istituto Superiore di Sanità , Rome , Italy.; c Division of Neurology, Department of Clinical and Experimental Medicine , Second University of Naples , Naples , Italy.; d I.R.C.C.S. Santa Lucia Foundation , Rome , Italy.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.